ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation
Summary
ICON reported fourth-quarter 2025 revenue of $2.11 billion and full-year revenue of $8.25 billion, alongside strong bookings and free cash flow. The company also closed its audit committee investigation and said it will restate prior financials after finding revenue recognition errors in 2023 and 2024. ICON said there was no impact on customers, operations, or cash flow, but it identified material weaknesses in internal controls and laid out a remediation plan. Management also updated backlog reporting methods, issued 2026 guidance, and highlighted improving demand from biotech funding and pharma spending. The company announced two new board appointments and one resignation effective in June 2026.
Classifications
industries
HealthTech
applications
AI & Machine learning
AskAI Classifications
Labels
SaaS
Clinical Trial Software
Healthcare Analytics
Linked Companies
ICON plc
$1B+